Skip to main content

PRPH

Stock

PRPH

Stock
Health Care
Diagnostics & Research

Performance overview

PRPH Price
Price Chart

Forward-looking statistics

Beta
0.26
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees83
Market cap$88.5M

Fundamentals

Enterprise value$30.2M
Revenue$5.8M
Revenue per employee—
Profit margin-2.22%
Debt to equity92.65

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$2.23
Dividend per share$1.49
Revenue per share$0.24
Avg trading volume (30 day)$1M
Avg trading volume (10 day)$447K
Put-call ratio—

Macro factor sensitivity

Growth-2.1
Credit+5.8
Liquidity+1.8
Inflation-5.1
Commodities-0.6
Interest Rates+1.4

Valuation

Dividend yield347.38%
PEG Ratio0.87
Price to sales2.97
P/E Ratio0.87
Enterprise Value to Revenue5.16
Price to book1.15

Upcoming events

Next earnings dayMay 20, 2025
Next dividend day—
Ex. dividend dayMay 24, 2022

News

Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now

ProPhase Labs (PRPH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Investment Research (March 5, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free